deltatrials
Recruiting OBSERVATIONAL NCT06929910

Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing. (GS_ZKM)

Evaluation of Systemic Therapy and the Effectiveness of Circulating Tumor DNA (ctDNA) Assays in Monitoring Treatment Response in Patients With Metastatic Cancer Undergoing K4Care Testing

Sponsor: Gene Solutions

Conditions Metastatic Cancers
Updated 3 times since 2025 Last updated: Jul 12, 2025 Started: Apr 9, 2025 Primary completion: Dec 31, 2026 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Metastatic Cancers and is currently actively recruiting participants. Gene Solutions leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2025 – ~Aug 2025 · 3 months · monthly snapshotNot Yet Recruiting~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Aug 2025 — Sep 2025 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  3. May 2025 — Aug 2025 [monthly]

    Not Yet Recruiting

    First recorded

Apr 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gene Solutions
  • The Medical Genetics Institute (MGI) of HCMC
Data source: Gene Solutions

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations